Think. Test. Treat TB PSA video
This resource is a 30-second video introduction to latent TB infection. The video features a healthcare provider and patient conversation about TB testing.
This resource is a 30-second video introduction to latent TB infection. The video features a healthcare provider and patient conversation about TB testing.
National surveys collected over 20 years in 35 African countries provides strong evidence that men who pay for sex should be classified as an ‘at-risk’ population for HIV.
People with HIV living in the 12 states that have not adopted the Medicaid expansion face limited access to health coverage. In 2018, across sampled states, 20% of people with HIV living in non-expansion states were uninsured compared to 6% in expansion states, and those in expansion states were more likely to have Medicaid coverage (46% v 30%).
The 90–90–90 targets were missed, but not by much. At the end of 2020, 84% of people living with HIV knew their HIV status, 87% of people living with HIV who knew their HIV status were accessing antiretroviral therapy, and 90% of people on treatment were virally suppressed.
This webinar was developed for healthcare professionals who care for persons diagnosed with TB infection or disease. The webinar includes a case study regarding diagnostic delays, presented by a speaker from Hidalgo County Health & Human Services.
The Heartland National TB Center created this factsheet based on the research conducted to develop the presentation for the webinar COVID-19/TB – Diagnostic Delays and Unrecognized Risk for Progression of LTBI to TB Disease. The webinar was developed in partnership between Heartland National TB Center and the National TB Nurse’s Coalition.
This 90-minute webinar was held for clinicians and others who provide services to TB patients or persons at risk for TB with significant alcohol and/or tobacco use.
This two-hour webinar was developed for clinicians in the United States who may treat or screen patients with tuberculosis, diabetes, or both diseases. The webinar includes a 90-minute presentation and a 30-minute question and answer session.
This 120-minute training was held for clinicians and others who are involved in the diagnosis of active TB. There are three presentations and a question and answer session.
This 90-minute webinar is the first of two webinars to highlight the NTCA/APHL Consensus Statement on the Use of Cepheid GeneXpert MTB/RIF Assay. The second webinar is GeneXpert: Examples From the Field.